A previous study showed that SMAD9 was significantly downregulated in the normal thyroid compared to the follicular variant of papillary thyroid carcinoma and follicular adenoma (Schulten et al., 2015). This evidence concerns the gene SMAD9 and thyroid gland papillary carcinoma.